Literature DB >> 15911757

Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters.

Nathan D Wolfe1, Walid Heneine, Jean K Carr, Albert D Garcia, Vedapuri Shanmugam, Ubald Tamoufe, Judith N Torimiro, A Tassy Prosser, Matthew Lebreton, Eitel Mpoudi-Ngole, Francine E McCutchan, Deborah L Birx, Thomas M Folks, Donald S Burke, William M Switzer.   

Abstract

The human T-lymphotropic viruses (HTLVs) types 1 and 2 originated independently and are related to distinct lineages of simian T-lymphotropic viruses (STLV-1 and STLV-2, respectively). These facts, along with the finding that HTLV-1 diversity appears to have resulted from multiple cross-species transmissions of STLV-1, suggest that contact between humans and infected nonhuman primates (NHPs) may result in HTLV emergence. We investigated the diversity of HTLV among central Africans reporting contact with NHP blood and body fluids through hunting, butchering, and keeping primate pets. We show that this population is infected with a wide variety of HTLVs, including two previously unknown retroviruses: HTLV-4 is a member of a phylogenetic lineage that is distinct from all known HTLVs and STLVs; HTLV-3 falls within the phylogenetic diversity of STLV-3, a group not previously seen in humans. We also document human infection with multiple STLV-1-like viruses. These results demonstrate greater HTLV diversity than previously recognized and suggest that NHP exposure contributes to HTLV emergence. Our discovery of unique and divergent HTLVs has implications for HTLV diagnosis, blood screening, and potential disease development in infected persons. The findings also indicate that cross-species transmission is not the rate-limiting step in pandemic retrovirus emergence and suggest that it may be possible to predict and prevent disease emergence by surveillance of populations exposed to animal reservoirs and interventions to decrease risk factors, such as primate hunting.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15911757      PMCID: PMC1142377          DOI: 10.1073/pnas.0501734102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Use of a generic polymerase chain reaction assay detecting human T-lymphotropic virus (HTLV) types I, II and divergent simian strains in the evaluation of individuals with indeterminate HTLV serology.

Authors:  A M Vandamme; K Van Laethem; H F Liu; M Van Brussel; E Delaporte; C M de Castro Costa; C Fleischer; G Taylor; U Bertazzoni; J Desmyter; P Goubau
Journal:  J Med Virol       Date:  1997-05       Impact factor: 2.327

2.  Evidence of infection with simian type D retrovirus in persons occupationally exposed to nonhuman primates.

Authors:  N W Lerche; W M Switzer; J L Yee; V Shanmugam; A N Rosenthal; L E Chapman; T M Folks; W Heneine
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  Brief report: infection of a laboratory worker with simian immunodeficiency virus.

Authors:  R F Khabbaz; W Heneine; J R George; B Parekh; T Rowe; T Woods; W M Switzer; H M McClure; M Murphey-Corb; T M Folks
Journal:  N Engl J Med       Date:  1994-01-20       Impact factor: 91.245

4.  Complete sequence of a novel highly divergent simian T-cell lymphotropic virus from wild-caught red-capped mangabeys (Cercocebus torquatus) from Cameroon: a new primate T-lymphotropic virus type 3 subtype.

Authors:  Laurent Meertens; Renaud Mahieux; Philippe Mauclère; John Lewis; Antoine Gessain
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

Review 5.  Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia/lymphotropic viruses.

Authors:  J P Slattery; G Franchini; A Gessain
Journal:  Genome Res       Date:  1999-06       Impact factor: 9.043

6.  Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection.

Authors:  R Mahieux; P Horal; P Mauclère; O Mercereau-Puijalon; M Guillotte; L Meertens; E Murphy; A Gessain
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

Review 7.  Human T-lymphotropic virus type II and neurological disease.

Authors:  Abelardo Araujo; William W Hall
Journal:  Ann Neurol       Date:  2004-07       Impact factor: 10.422

8.  Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes.

Authors:  W M Switzer; D Pieniazek; P Swanson; H H Samdal; V Soriano; R F Khabbaz; J E Kaplan; R B Lal; W Heneine
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

9.  Simian T-cell lymphotropic virus type 1 from Mandrillus sphinx as a simian counterpart of human T-cell lymphotropic virus type 1 subtype D.

Authors:  R Mahieux; C Chappey; M C Georges-Courbot; G Dubreuil; P Mauclere; A Georges; A Gessain
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  The role of evolution in the emergence of infectious diseases.

Authors:  Rustom Antia; Roland R Regoes; Jacob C Koella; Carl T Bergstrom
Journal:  Nature       Date:  2003-12-11       Impact factor: 49.962

View more
  153 in total

1.  Primates and primatologists: social contexts for interspecies pathogen transmission.

Authors:  G A Engel; L Jones-Engel
Journal:  Am J Primatol       Date:  2011-09-19       Impact factor: 2.371

2.  A new and frequent human T-cell leukemia virus indeterminate Western blot pattern: epidemiological determinants and PCR results in central African inhabitants.

Authors:  Claudia Filippone; Sylviane Bassot; Edouard Betsem; Patricia Tortevoye; Micheline Guillotte; Odile Mercereau-Puijalon; Sabine Plancoulaine; Sara Calattini; Antoine Gessain
Journal:  J Clin Microbiol       Date:  2012-03-07       Impact factor: 5.948

3.  Systematic Review of Important Viral Diseases in Africa in Light of the 'One Health' Concept.

Authors:  Ravendra P Chauhan; Zelalem G Dessie; Ayman Noreddin; Mohamed E El Zowalaty
Journal:  Pathogens       Date:  2020-04-20

Review 4.  The origin of porcine endogenous retroviruses (PERVs).

Authors:  Joachim Denner
Journal:  Arch Virol       Date:  2021-02-06       Impact factor: 2.574

5.  Human T-cell lymphotropic virus type 3: complete nucleotide sequence and characterization of the human tax3 protein.

Authors:  Sara Calattini; Sébastien Alain Chevalier; Renan Duprez; Philippe Afonso; Alain Froment; Antoine Gessain; Renaud Mahieux
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death.

Authors:  David Sibon; Anne-Sophie Gabet; Marc Zandecki; Christiane Pinatel; Julien Thête; Marie-Hélène Delfau-Larue; Samira Rabaaoui; Antoine Gessain; Olivier Gout; Steven Jacobson; Franck Mortreux; Eric Wattel
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

7.  New Streptococcus pneumoniae clones in deceased wild chimpanzees.

Authors:  Fang Chi; Michaela Leider; Fabian Leendertz; Carina Bergmann; Christophe Boesch; Svenja Schenk; Georg Pauli; Heinz Ellerbrok; Regine Hakenbeck
Journal:  J Bacteriol       Date:  2007-06-22       Impact factor: 3.490

Review 8.  Evolution of feline immunodeficiency virus in Felidae: implications for human health and wildlife ecology.

Authors:  Jill Pecon-Slattery; Jennifer L Troyer; Warren E Johnson; Stephen J O'Brien
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

9.  Major histocompatibility complex class II transactivator CIITA is a viral restriction factor that targets human T-cell lymphotropic virus type 1 Tax-1 function and inhibits viral replication.

Authors:  Giovanna Tosi; Greta Forlani; Vibeke Andresen; Marco Turci; Umberto Bertazzoni; Genoveffa Franchini; Guido Poli; Roberto S Accolla
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

Review 10.  Implication of the HTLV-I bZIP factor gene in the leukemogenesis of adult T-cell leukemia.

Authors:  Yorifumi Satou; Masao Matsuoka
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.